You are here

Aeterna Zentaris

AEterna Phase 3 BHP Cetrorelix Trial Misses Primary Endpoint

WSJ Online

Mon, 08/17/09 - 09:21 am

Aeterna Zentaris

Keryx, Aeterna to move ahead with late-stage study

Yahoo/AP

Mon, 08/3/09 - 11:37 am

Aeterna Zentaris

AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction

Yahoo

Tue, 07/7/09 - 10:28 am

Aeterna Zentaris

AEterna Zentaris share offer to net $9.3 million

Yahoo/AP

Sat, 06/20/09 - 09:24 am

Aeterna Zentaris

AEterna Zentaris to Raise US$10 Million from Institutional Investors at US$1.88 Per Share

Marketwatch

Fri, 06/19/09 - 09:53 am

Aeterna Zentaris

6 Healthcare Stocks to Watch

Seeking Alpha

Tue, 06/16/09 - 08:41 am

Abbott Laboratories

Arena Pharmaceuticals

Aeterna Zentaris

Jazz Pharmaceuticals

KV Pharmaceutical

Drug stocks fall sharply; Jazz, AEterna soar

Marketwatch

Mon, 06/15/09 - 07:43 pm

Jazz Pharmaceuticals

Aeterna Zentaris

AEterna Zentaris cancer drug missed trial goal

Yahoo/AP

Mon, 06/8/09 - 09:49 pm

Aeterna Zentaris

Aeterna Zentaris signs deal with Sanofi-Aventis

Yahoo/AP

Fri, 03/6/09 - 12:57 pm

Aeterna Zentaris

benign prostatic hyperplasia

Pages